Literature DB >> 18060773

Synthesis and biological activity of phosphatidylinositol-3,4,5-trisphosphorothioate.

Honglu Zhang1, Yong Xu, Nicolas Markadieu, Renaud Beauwens, Christophe Erneux, Glenn D Prestwich.   

Abstract

Metabolically-stabilized analogs of PtdIns(3,4,5)P(3) have shown long-lived agonist activity for cellular events mediated by this phosphoinositide. We describe an efficient method for the total asymmetric synthesis of the trisphosphorothioate (PT) analog of PtdIns(3,4,5)P(3). Intracellular delivery of dipalmitoyl PtdIns(3,4,5)PT(3)-mimicked insulin in activating sodium transport in A6 cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18060773      PMCID: PMC2255567          DOI: 10.1016/j.bmcl.2007.11.041

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  22 in total

Review 1.  Phosphoinositide 3-kinase signalling--which way to target?

Authors:  Matthias P Wymann; Marketa Zvelebil; Muriel Laffargue
Journal:  Trends Pharmacol Sci       Date:  2003-07       Impact factor: 14.819

2.  Analogs of inosine 5'-phosphate with phosphorus-nitrogen and phosphorus-sulfur bonds. Binding and kinetic studies with inosine 5'-phosphate dehydrogenase.

Authors:  A Hampton; L W Brox; M Bayer
Journal:  Biochemistry       Date:  1969-06       Impact factor: 3.162

3.  Adenosine 5'-phosphorothioate. A nucleotide analog that is a substrate, competitive inhibitor, or regulator of some enzymes that interact with adenosine 5'-phosphate.

Authors:  A W Murray; M R Atkinson
Journal:  Biochemistry       Date:  1968-11       Impact factor: 3.162

4.  Intracellular delivery of phosphoinositides and inositol phosphates using polyamine carriers.

Authors:  S Ozaki; D B DeWald; J C Shope; J Chen; G D Prestwich
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

5.  Phosphatidylinositol 3,4,5-trisphosphate: an early mediator of insulin-stimulated sodium transport in A6 cells.

Authors:  Nicolas Markadieu; Daniel Blero; Alain Boom; Christophe Erneux; Renaud Beauwens
Journal:  Am J Physiol Renal Physiol       Date:  2004-04-20

6.  Hormone effects on transport in cultured epithelia with high electrical resistance.

Authors:  J S Handler; F M Perkins; J P Johnson
Journal:  Am J Physiol       Date:  1981-03

7.  Stabilized phosphatidylinositol-5-phosphate analogues as ligands for the nuclear protein ING2: chemistry, biology, and molecular modeling.

Authors:  Wei Huang; Honglu Zhang; Foteini Davrazou; Tatiana G Kutateladze; Xiaobing Shi; Or Gozani; Glenn D Prestwich
Journal:  J Am Chem Soc       Date:  2007-05-01       Impact factor: 15.419

Review 8.  Phosphoinositide signaling; from affinity probes to pharmaceutical targets.

Authors:  Glenn D Prestwich
Journal:  Chem Biol       Date:  2004-05

9.  An inositol tetrakisphosphate-containing phospholipid in activated neutrophils.

Authors:  A E Traynor-Kaplan; A L Harris; B L Thompson; P Taylor; L A Sklar
Journal:  Nature       Date:  1988-07-28       Impact factor: 49.962

10.  Intracellular delivery of phosphatidylinositol (3,4,5)-trisphosphate causes incorporation of glucose transporter 4 into the plasma membrane of muscle and fat cells without increasing glucose uptake.

Authors:  Gary Sweeney; Rami R Garg; Rolando B Ceddia; Dailin Li; Manabu Ishiki; Romel Somwar; Leonard J Foster; Paul O Neilsen; Glenn D Prestwich; Assaf Rudich; Amira Klip
Journal:  J Biol Chem       Date:  2004-05-27       Impact factor: 5.157

View more
  2 in total

1.  5-Stabilized phosphatidylinositol 3,4,5-trisphosphate analogues bind Grp1 PH, inhibit phosphoinositide phosphatases, and block neutrophil migration.

Authors:  Honglu Zhang; Ju He; Tatiana G Kutateladze; Takahiro Sakai; Takehiko Sasaki; Nicolas Markadieu; Christophe Erneux; Glenn D Prestwich
Journal:  Chembiochem       Date:  2010-02-15       Impact factor: 3.164

2.  A scalable synthesis of the IP7 isomer, 5-PP-Ins(1,2,3,4,6)P5.

Authors:  Honglu Zhang; James Thompson; Glenn D Prestwich
Journal:  Org Lett       Date:  2009-04-02       Impact factor: 6.005

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.